feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Anthropic AI triggers IT selloff

trending

UPSC CSE 2026 notification

trending

India face South Africa T20

trending

Tanker stalls Mumbai-Pune expressway

trending

HAL out of stealth jet

trending

Pakistan vs Ireland warm-up

trending

India, Afghanistan U19 semifinal

trending

AI music generator platform

trending

Afghanistan vs West Indies match

Home / Health / Wegovy Pill Ends 'Food Noise' for Mom

Wegovy Pill Ends 'Food Noise' for Mom

4 Feb

Summary

  • Wegovy pill offers a more affordable alternative to weight loss injections.
  • The pill completely eliminated 'food noise' for one mother within days.
  • Novo Nordisk plans to submit the Wegovy pill for UK regulatory approval in 2026.
Wegovy Pill Ends 'Food Noise' for Mom

Sharon Vickers, a 46-year-old mother of five from Greenville, South Carolina, has shared her positive experience with the new Wegovy pill. Previously struggling with her weight, Vickers lost 5 st 3 lb after gastric sleeve surgery in January 2025, but then encountered a weight plateau. She found the $500 monthly cost of GLP-1 injections prohibitive and was hesitant about self-injection.

Discovering the Wegovy pill, which launched in the US in January 2026, Vickers secured a prescription for $149 for a 30-day supply. Within five days of starting the pill, she reported that it completely eliminated 'food noise,' significantly reducing her desire to snack. She has experienced no side effects and is hopeful about reaching her goal weight of 12 st 2 lb.

Novo Nordisk is actively working towards bringing the Wegovy pill to the UK, with a regulatory submission planned for 2026. Clinical trials indicated that patients using the Wegovy pill lost an average of 16.6 percent of their body weight over a year, with roughly a third losing 20 percent or more.

Vickers is now considering long-term use of the pill to maintain her weight loss, concerned about the potential return of 'food noise' if she stops taking it. The convenience and affordability of the pill have made it a viable option for her weight management journey.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
In trials, patients taking the Wegovy pill lost an average of 16.6 percent of their body weight after just over a year, with about a third losing 20 percent or more.
The Wegovy pill costs $149 for a 30-day supply, while weight loss injections were found to be approximately $500 per month.
Novo Nordisk is planning a regulatory submission for the Wegovy pill in the UK in 2026.

Read more news on

Healthside-arrow
•

You may also like

Wegovy Pill Launch a Resounding Success, Says CEO

14 hours ago • 5 reads

article image

Novo Nordisk CEO: Wegovy Price Cuts Hurt, But Invest in Future

2 hours ago • 1 read

article image

Ozempic Patents Expire: Generics Set to Slash Drug Costs Globally

15 Jan • 187 reads

article image

Supermarkets Cash In on Weight-Loss Drug Trend

17 Jan • 96 reads

article image

UK Greenlights Max Wegovy Dose for Obesity Patients

16 Jan • 111 reads

article image